STERIS plc Q2 FY2027 results
$264.32+4.29%
STERIS plc reported revenue of $1.59 billion, up 8.8% from a year earlier, net income of $214 million and diluted earnings per share of $2.19 against $1.94 for the second quarter of fiscal 2027 (the three months to 30 Sep 2026).
From its quarterly report, the results first announced on 4 Nov 2026. Compiled and checked by AapWire.
Q2 FY2027 against Q2 FY2026
Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.
| Measure | Q2 FY2027 | Q2 FY2026 | Change |
|---|---|---|---|
| Revenue | $1.59B | $1.46B | +8.8% |
| Gross profit | $710.8M | $645.9M | +10.0% |
| Gross margin | 44.7% | 44.2% | +0.5 pts |
| Operating income | $294.3M | $265.8M | +10.7% |
| Operating margin | 18.5% | 18.2% | +0.3 pts |
| Net income | $213.7M | $191.9M | +11.4% |
| Diluted EPS | $2.19 | $1.94 | +12.9% |
| Operating cash flow | $289.0M | $287.8M | +0.4% |
| Capital expenditure | $76.10M | $86.50M | −12.0% |
| Free cash flow | $212.9M | $201.3M | +5.8% |
Operating KPIs for the quarter
| KPI | Q2 FY2027 | Change on a year |
|---|---|---|
| Product revenue | $816.9M | up 9.6% |
| Service revenue | $771.7M | up 7.9% |
| Capital equipment revenue | $1.7M | down 19.0% |
| Healthcare revenue | $1.1B | up 8.6% |
| AST revenue | $295.6M | up 5.0% |
| Life Sciences (revenue) | $170.6M | up 17.7% |
| United States revenue | $1.2B | up 9.2% |
| Ireland revenue | $26.0M | down 4.8% |
Earlier quarters
| Quarter | Period end | Revenue | Change on a year | Diluted EPS |
|---|---|---|---|---|
| Q2 FY2027 | 30 Sep 2026 | $1.59B | +8.8% | $2.19 |
| Q1 FY2027 | 30 Jun 2026 | $1.49B | +7.3% | $2.04 |
| Q4 FY2026 | 31 Mar 2026 | $1.59B | +7.3% | $2.24 |
| Q3 FY2026 | 31 Dec 2025 | $1.50B | +9.2% | $1.96 |
| Q2 FY2026 | 30 Sep 2025 | $1.46B | +9.9% | $1.94 |
| Q1 FY2026 | 30 Jun 2025 | $1.39B | +8.7% | $1.79 |
| Q4 FY2025 | 31 Mar 2025 | $1.48B | +4.3% | $1.48 |
| Q3 FY2025 | 31 Dec 2024 | $1.37B | +5.6% | $1.75 |
More on STERIS plc: financial statements · revenue · earnings per share
STE's results, as they are filed.
Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.